Summary
In hypertensive patients, the effect of propranolol and of the optical isomers of N-isopropyl-p-nitrophenylethanolamine (INPEA) on blood pressure was studied. Single oral doses of 40 mg propranolol, 700 mg (−)-INPEA and 700 mg (+)-INPEA decreased supine systolic as well as standing systolic and diastolic blood pressure. Single intravenous doses of 75 mg (−)-INPEA and 75 mg (+)-INPEA lowered supine systolic and diastolic blood pressure. The antihypertensive action of the beta adrenergic blocking levorotatory isomer of INPEA and of the dextrorotatory isomer, which is devoid of beta adrenergic blocking activity, did not differ. It is concluded from these results that the antihypertensive action of beta adrenergic blocking agents is not related to their beta receptor blocking effect.
Similar content being viewed by others
References
Almirante, L., and W. Murmann: Relationship between configuration and adrenergic beta-receptor blocking activity of optical isomers of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA). J. med. Chem. 9, 650 (1966).
Epstein, S.E., B.F. Robinson, R.L. Kahler, and E. Braunwald: Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J. clin. Invest. 44, 1745 (1965).
Frohlich, E. D., R. C. Tarazi, H. P. Dustan, and I. H. Page: The paradox of beta-adrenergic blockade in hypertension. Circulation 37, 417 (1968).
Hahn, R. A., R. C. Pendleton, and J. R. Wardell, jr.: A comparative study of the beta adrenergic blocking activities of propranolol and INPEA. J. Pharmacol. exp. Ther. 161, 111 (1968).
Harris, W. S., C. D. Schoenfeld, R. H. Brooks, and A.M. Weissler: Reversal of epinephrine effects in the human by beta-adrenergic blockade. Clin. Res. 12, 337 (1964).
Howe, R., and R. G. Shanks: Optical isomers of propranolol. Nature 210, 1336 (1966).
Humphreys, W. R. u. D. G. Delvin: Ineffectiveness of propanolol in hypertensive Jamaicans. Brit. med. J. 1968 II, 601.
Kukovetz, W.R., u. G. Pöch: Die Hemmung mechanischer und metabolischer Katecholaminwirkungen durch Isopropylmethoxamin und Kö 592 am Herzen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 256, 310 (1967).
Lord, E.: The use of range in place of standard deviation in the t-test. Biometrica 34, 41 (1947).
Paterson, J.W., and C.T. Dollery: Effect of propranolol in mild hypertension. Lancet 1966 II, 1148.
Prichard, B.N.C.: Hypotensive action of propranolol. Brit. med. J. 1964 I, 1227.
— , and P.M.S. Gillam: Use of propranolol (Inderal) in treatment of hypertension. Brit. med. J. 1964 II, 725.
, and Propranolol in hypertension. Amer. J. Cardiol. 18, 387 (1966).
— — Treatment of hypertension with propranolol. Brit. med. J. 1969 I, 7.
Rahn, K. H., u. T. Ockenga: Über die Bezichungen zwischen den β-adrenolytischen Wirkungen und dem Einfluß auf Herzfrequenz und Herzminutenvolumen von β-Receptoren blockierenden Substanzen. Klin. Wschr. 45, 1087 (1967).
Richards, F. A.: Propranolol in hypertension. Amer. J. Cardiol. 18, 384 (1966).
Richardson, D. W., J. Ferund, A. S. Gear, H. P. Mank, and L.W. Preston: Effect of propranolol on elevated arterial blood pressure. Circulation 37, 534 (1968).
Schröder, G., and L. Werkö: Hemodynamic studies and clinical experience with nethalide, a beta-adrenergic blocking agent. Amer. J. Cardiol. 15, 58 (1965).
Waal, H. J.: Hypotensive action of propranolol. Clin. Pharmacol. Ther. 7, 588 (1966).
Author information
Authors and Affiliations
Additional information
A preliminary report has been presented. H. J. Gilfrich, K. H. Rahn und F. W. Schmahl, Verhandlungen der Deutschen Gesellschaft für Innere Medizin 74, 562 (1968).
Rights and permissions
About this article
Cite this article
Gilfrich, H.J., Rahn, K.H. & Schmahl, F.W. A comparison of the antihypertensive action of propranolol and the optical isomers of N-isopropyl-p-nitrophenylethanolamine (INPEA). Pharmacol. Clin. 2, 30–33 (1969). https://doi.org/10.1007/BF00404183
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00404183